Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses.
D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology*; D000915:Antibody Affinity; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D003429:Cross Reactions; D004195:Disease Models, Animal; D017353:Gene Deletion; D006023:Glycoproteins / Q000235:genetics / Q000276:immunology; D019302:HIV Envelope Protein gp160 / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D013154:Spleen / Q000276:immunology; D019444:Vaccines, DNA / Q000235:genetics / Q000276:immunology*
D000914:Antibodies, Viral; C033904:GP 140; D006023:Glycoproteins; D019302:HIV Envelope Protein gp160; D019444:Vaccines, DNA